Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatches Switz Regulatory News (WOSG)

Share Price Information for Watches Switz (WOSG)

Share Price is delayed by 15 minutes
Get Live Data
719.50    -10.50 (-1.44%)
Bid:
713.00
Ask:
714.50
Spread: 1.50 (0.21%)
Market Cap: £1.67b
WOSG Live PriceLast checked at - London Stock Exchange

Intraday Watches Switz Share Chart

Updated notice for Q4 FY22 Trading Update

9 May 2022 11:30

RNS Number : 7814K
Watches of Switzerland Group PLC
09 May 2022
Β 

Β 

Watches of Switzerland Group PLC

Β 

Updated notice for Q4 FY22 Trading Update

Β 

Watches of Switzerland Group PLC provides an updated notice for the announcement date for Q4 FY22 trading update (for the 13 and 52 weeks ending 1 May 2022).

Β 

The Q4 FY22 trading update will now be released a day earlier on Wednesday 18th May 2022 to accommodate an unforeseen change in diary commitments.

Β 

Q4 FY22 trading was in line with expectations, and we remain confident in the Group's prospects for FY23.

Β 

A conference call for analysts and investors will be held at 8.00am (UK time) on the day, details for which will be provided in the announcement.

Β 

Β 

Contacts

The Watches of Switzerland Group

Bill Floydd, CFO +44 (0) 207 317 4600

Caroline Browne, Group Finance Director +44 (0) 1162 817 420

investor.relations@thewosgroup.com

Β 

Headland

Lucy Legh / Rob Walker / Joanna Clark +44 (0) 20 3805 4822

wos@headlandconsultancy.com

Β 

Β 

About the Watches of Switzerland Group

Β 

The Watches of Switzerland Group is the UK's largest luxury watch retailer, operating in both the UK and US, comprising five prestigious brands; Watches of Switzerland (UK and US), Mappin & Webb (UK), Goldsmiths (UK), Mayors (US) and Betteridge (US), with complementary jewellery offering.

Β 

As at 30 January 2022, the Watches of Switzerland Group has 171 stores across the UK and US including 51 dedicated mono-brand boutiques in partnership with Rolex, TAG Heuer, Breitling, OMEGA, Tudor, Audemars Piguet, Grand Seiko, Bvlgari and FOPE and has a leading presence in Heathrow Airport with representation in Terminals 2, 3, 4 and 5 as well as seven retail websites.

Β 

The Watches of Switzerland Group is proud to be the UK's largest retailer for Rolex, Cartier, OMEGA, TAG Heuer and Breitling watches.

Β 

Mappin & Webb holds Royal warrants as goldsmiths, silversmiths and jeweller to Her Majesty The Queen and silversmiths to His Royal Highness The Prince of Wales. The Mappin & Webb master jeweller has been Crown Jeweller, custodian of the Crown Jewels of Her Majesty The Queen since 2012.

Β 

https://www.thewosgroupplc.com

Β 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Watches of Switzerland Group PLC shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser.

Β 

Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NORUKRRRUWUVRAR
Date   Source Headline
9th Jul 20267:00 amRNS-RInvestor Presentation via Engage Investor
26th Jun 20267:00 amRNSNotice of FY26 Results
25th Jun 202612:17 pmRNSHolding(s) in Company
19th Jun 20269:07 amRNSHolding(s) in Company
1st Jun 20264:56 pmRNSHolding(s) in Company
29th May 202610:50 amRNSHolding(s) in Company
14th May 20267:00 amRNSFY26 Trading Update
13th May 202612:09 pmRNSHolding(s) in Company
28th Apr 20264:26 pmRNSHolding(s) in Company
2nd Mar 20265:19 pmRNSDirector/PDMR Shareholding
27th Feb 202610:44 amRNSDirector/PDMR Shareholding
19th Feb 20262:00 pmRNSAppointment of Non-Executive Director
4th Feb 20267:00 amRNSQ3 FY26 Trading Update
22nd Jan 20265:01 pmRNSAcquisition of four new US showrooms
8th Dec 20255:12 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSH1 FY26 Results
2nd Dec 20257:00 amRNS-RInvestor Presentation via Engage Investor
25th Nov 20257:00 amRNSChange of Adviser
19th Nov 20254:43 pmRNSDirectorate change
17th Nov 20251:37 pmRNSHolding(s) in Company
14th Nov 20252:52 pmRNSHolding(s) in Company
7th Nov 202512:40 pmRNSHolding(s) in Company
6th Nov 20257:00 amRNSH1 FY26 Trading Update
13th Oct 20257:00 amRNSNotice of H1 trading update
4th Sep 20252:21 pmRNSDirector/PDMR Shareholding
4th Sep 20258:41 amRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
31st Jul 202511:55 amRNSAnnual Financial Report
29th Jul 20253:40 pmRNSDirector Declaration
28th Jul 202511:36 amRNSDirector/PDMR Shareholding
7th Jul 202511:37 amRNSHolding(s) in Company
3rd Jul 20257:00 amRNSFY25 Results
30th Jun 20251:41 pmRNSTotal Voting Rights
23rd Jun 20252:15 pmRNSHolding(s) in Company
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20257:00 amRNSTransaction in Own Shares
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSTransaction in Own Shares
10th Jun 20257:00 amRNSTransaction in Own Shares
9th Jun 20257:00 amRNSTransaction in Own Shares
6th Jun 20257:00 amRNSTransaction in Own Shares
5th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20253:04 pmRNSTotal Voting Rights
30th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.